immune checkpoint inhibitor

Shares in South Korea’s leading entertainment companies are rallying amid growing signs that China will likely lift its longstanding ban on Ko...

The Korea Advanced Institute of Science & Technology (KAIST) announced on Thursday that it signed a memorandum of understanding (MOU) with the I...

South Korea's Hanmi Pharmaceutical Co. announced on Tuesday that it has received approval for the phase 1 clinical trial plan of the immune-oncology...

New drug development company ABL Bio Inc. announced on Thursday that it has received approval from the Ministry of Food and Drug Safety of South Kor...

South Korean natural killer cell drug maker NKMax Co. announced in a regulatory filing on Friday that it has signed a supply contract with China's S...

HLB Co. announced on May 17 that it has submitted a new drug application (NDA) to the US Food and Drug Administration (FDA) for the approval of Rivo...

South Korean pharmaceuticals firm Hanall Biopharma Co. is investing in Interon Laboratories, a US biotech firm that finds and develops treatments fo...

The global venture capital ecosystem has been contracting since the second quarter of last year, hit by rising inflation and rate hikes. New ...

Korea Ginseng Corporation (KGC), a wholly-owned subsidiary of KT&G Corporation, has set up its first interactive cafe in the global market where...